| Sara Eileen Knoblauch, CCC-SLP | |
|
380 Woods Cove Rd, Scottsboro, AL 35768-2428 | |
| (256) 259-4840 | |
| (256) 259-4830 |
| Full Name | Sara Eileen Knoblauch |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 380 Woods Cove Rd, Scottsboro, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215057138 | NPI | - | NPPES |
| 51537983 | Other | AL | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2532 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sara Eileen Knoblauch, CCC-SLP 380 Woods Cove Rd, Scottsboro, AL 35768-2428 Ph: (256) 259-4840 | Sara Eileen Knoblauch, CCC-SLP 380 Woods Cove Rd, Scottsboro, AL 35768-2428 Ph: (256) 259-4840 |
News Archive
Inova Labs, a privately held medical device company focused on developing innovative products for the Chronic Obstructive Pulmonary Disease (COPD) market, announced today that it has secured a Series B round of equity financing for up to $17.5M from an investment syndicate led by Latterell Venture Partners, based in San Francisco, Calif.
The first study to examine nonalcoholic fatty liver disease (NAFLD) among different ethnic and racial groups in the United States finds that Hispanics may be at a higher risk of developing the condition. The study is published in Hepatology, the official journal of the American Association for the Study of Liver Diseases (AASLD). Published by John Wiley & Sons, Inc., Hepatology is available online via Wiley InterScience.
The expression 'prevention is better than a cure' is a truism when it comes to vaccine research. European scientists in various EU-funded projects are hard at work developing new vaccines, treatments and diagnostic tools against some of the deadliest and most virulent viruses, including strains of avian flu.
Calithera Biosciences, a company developing novel oncology therapeutics, today announced the completion of a Series A financing totaling $40 million. Morgenthaler Ventures led the financing with U.S. Venture Partners, Advanced Technology Ventures, Delphi Ventures and Mission Bay Capital also participating in the round. The capital will be used to support the company's pioneering efforts to develop activators of caspases, the proteases that promote apoptotic cell death, for the treatment of cancer and other proliferative diseases.
› Verified 3 days ago
Mrs. Hannah Rebecca Black, MS CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 412 W Cloverdale Rd, Scottsboro, AL 35768 Phone: 256-259-1505 | |
Trisha Mckenzie, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 305 W Peachtree St, Scottsboro, AL 35768 Phone: 256-609-6946 | |
Kennedy George, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 412 W Cloverdale Rd, Scottsboro, AL 35768 Phone: 256-259-1505 | |
Mrs. J Talese Holcomb Berry, MSCCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1531 S Broad St, Scottsboro, AL 35768 Phone: 256-259-4433 Fax: 256-259-4435 | |
Theia Ann Chaffin, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 380 Woods Cove Rd, Scottsboro, AL 35768 Phone: 256-259-4840 Fax: 256-259-4830 | |
Clyde Wilson Butler, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 380 Woods Cove Rd, Scottsboro, AL 35768 Phone: 256-259-4840 Fax: 256-259-4830 |